Your browser doesn't support javascript.
loading
Fc-engineered antibody therapeutics with improved efficacy against COVID-19.
Yamin, Rachel; Jones, Andrew T; Hoffmann, Hans-Heinrich; Kao, Kevin S; Francis, Rebecca L; Sheahan, Timothy P; Baric, Ralph S; Rice, Charles M; Ravetch, Jeffrey V; Bournazos, Stylianos.
Affiliation
  • Yamin R; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.
  • Jones AT; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.
  • Hoffmann HH; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • Kao KS; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.
  • Francis RL; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.
  • Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Rice CM; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Ravetch JV; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • Bournazos S; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY.
Res Sq ; 2021 May 27.
Article in En | MEDLINE | ID: mdl-34075373
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Res Sq Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Res Sq Year: 2021 Document type: Article Country of publication: